Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
J Antimicrob Chemother
; 77(1): 38-48, 2021 12 24.
Article
in English
| MEDLINE | ID: covidwho-1621627
ABSTRACT
OBJECTIVES:
Increasing spread of resistance could jeopardize the use of antifolates against MRSA infections.METHODS:
We compared the prevalence of phenotypic trimethoprim/sulfamethoxazole resistance in 20â534 clinical Staphylococcus aureus isolates (19â096 MSSA and 1438 MRSA) of non-redundant patients at Heidelberg University Hospital over 8 years and performed WGS on trimethoprim/sulfamethoxazole-resistant MRSA.RESULTS:
From 2012 to 2019, trimethoprim/sulfamethoxazole resistance in MSSA (674/19â096; 3.5%) ranged between 1.5% and 7.2% and in MRSA (135/1438; 9.4%) between 0.5% and 20.2%, reaching a peak in 2016 and 2018, respectively (Ptrendâ<â0.001). Trimethoprim/sulfamethoxazole resistance was more likely in outpatients than inpatients (Pâ=â0.005), younger patients (Pâ<â0.001), skin and soft tissue infections (SSTIs) (MRSA only, Pâ=â0.05), submissions from pulmonology (MRSA only, Pâ=â0.001), the upper respiratory tract (MSSA only, Pâ<â0.001) and general surgery (MSSA only, Pâ=â0.001). WGS of 76 trimethoprim/sulfamethoxazole-resistant MRSA revealed that 59% belonged to major pandemic CA-MRSA clones (ST22, ST8, ST398, ST772, ST30), 47% harboured Panton-Valentine leucocidin (PVL), 97% SCCmec IV/V, 71% dfrG and 28% dfrA. SNP-based phylogeny of trimethoprim/sulfamethoxazole-resistant MRSA core genomes favoured independent introduction over clonal expansion as the source, most prominently of dfrA+ trimethoprim/sulfamethoxazole-resistant ST22 MRSA from the Gaza Strip.CONCLUSIONS:
The presented results support that trimethoprim/sulfamethoxazole-resistant S. aureus, formerly associated with SSTI from outpatients and S. aureus in the (sub)tropics, is on the rise in the temperate zone, potentially due to migration. Closer monitoring of trimethoprim/sulfamethoxazole resistance in S. aureus is recommended to safeguard the effectiveness of antifolate compounds.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Staphylococcal Infections
/
Trimethoprim, Sulfamethoxazole Drug Combination
/
Methicillin-Resistant Staphylococcus aureus
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
J Antimicrob Chemother
Year:
2021
Document Type:
Article
Affiliation country:
Jac
Similar
MEDLINE
...
LILACS
LIS